↓ Skip to main content

Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulat…

Overview of attention for article published in BMC Cancer, January 2013
Altmetric Badge

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
69 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Pegfilgrastim prophylaxis is associated with a lower risk of hospitalization of cancer patients than filgrastim prophylaxis: a retrospective United States claims analysis of granulocyte colony-stimulating factors (G-CSF)
Published in
BMC Cancer, January 2013
DOI 10.1186/1471-2407-13-11
Pubmed ID
Authors

Arash Naeim, Henry J Henk, Laura Becker, Victoria Chia, Sejal Badre, Xiaoyan Li, Robert Deeter

Abstract

Myelosuppressive chemotherapy can lead to dose-limiting febrile neutropenia. Prophylactic use of recombinant human G-CSF such as daily filgrastim and once-per-cycle pegfilgrastim may reduce the incidence of febrile neutropenia. This comparative study examined the effect of pegfilgrastim versus daily filgrastim on the risk of hospitalization.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 69 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 20%
Student > Master 9 13%
Student > Ph. D. Student 6 9%
Student > Doctoral Student 5 7%
Student > Bachelor 4 6%
Other 13 19%
Unknown 18 26%
Readers by discipline Count As %
Medicine and Dentistry 21 30%
Nursing and Health Professions 6 9%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Psychology 4 6%
Agricultural and Biological Sciences 3 4%
Other 9 13%
Unknown 22 32%